dx.doi.org/10.1016/j.ejca.2015.12.031, hdl.handle.net/1765/84968
European Journal of Cancer
Department of Pediatrics

Driessen, E.M.C, Pinhanços, S.S, Schneider, P, de Lorenzo, P, Valsecchi, M.G, Pieters, R, & Stam, R.W. (2016). Versican expression is an adverse prognostic factor in MLL-rearranged infant acute lymphoblastic leukaemia. European Journal of Cancer, 57, 87–90. doi:10.1016/j.ejca.2015.12.031